Social determinants, multimorbidity, and patterns of end-of-life care in older adults dying from cancer

Journal of Geriatric Oncology

Volumn 8, Issue 2, 2017, Pages 117-124

  Koroukian, Siran M ^a,b   Schiltz, Nicholas K ^a   Warner, David F ^c   Given, Charles W ^d   Schluchter, Mark ^a,b   Owusu, Cynthia ^a,b   Berger, Nathan A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Chronic conditions; End of life care; Functional limitations; Geriatric syndromes; Hospice; Social determinants of health

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; DYING; EDUCATIONAL STATUS; FEMALE; FUNCTIONAL STATUS; HEALTH CARE QUALITY; HOSPICE; HOSPITAL MORTALITY; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; OUTCOME ASSESSMENT; RACE; SOCIAL DETERMINANTS OF HEALTH; TERMINAL CARE; AGE; HEALTH SURVEY; HOSPITAL EMERGENCY SERVICE; MORTALITY; MULTIPLE CHRONIC CONDITIONS; NEOPLASM; RISK FACTOR; SOCIOECONOMICS; STANDARDS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH SURVEYS; HOSPICES; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MULTIMORBIDITY; NEOPLASMS; POPULATION SURVEILLANCE; QUALITY OF HEALTH CARE; RISK FACTORS; SOCIOECONOMIC FACTORS; TERMINAL CARE;

EID: 85005992556     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2016.10.001     Document Type: Article

References (45)

1. [1] Earle, C.C., Neville, B.A., Landrum, M.B., Ayanian, J.Z., Block, S.D., Weeks, J.C., Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:2 (Jan 15 2004), 315–321.
2. [2] Toole, M., Lutz, S., Johnstone, P.A., Radiation oncology quality: aggressiveness of cancer care near the end of life. J Am Coll Radiol 9:3 (Mar 2012), 199–202.
3. [3] Cheung, M.C., Earle, C.C., Rangrej, J., et al. Impact of aggressive management and palliative care on cancer costs in the final month of life. Cancer 121:18 (2015 Sep 15), 3307–3315.
4. [4] Saito, A.M., Landrum, M.B., Neville, B.A., Ayanian, J.Z., Earle, C.C., The effect on survival of continuing chemotherapy to near death. BMC Palliat Care, 10, 2011, 14.
5. [5] Kirolos, I., Tamariz, L., Schultz, E.A., Diaz, Y., Wood, B.A., Palacio, A., Interventions to improve hospice and palliative care referral: a systematic review. J Palliat Med 17:8 (Aug 2014), 957–964.
6. [6] Prince-Paul, M., When hospice is the best option: an opportunity to redefine goals. Oncology (Williston Park) 23:4 Suppl. Nurse Ed (Apr 2009), 13–17.
7. [7] Lopez-Acevedo, M., Lowery, W.J., Lowery, A.W., Lee, P.S., Havrilesky, L.J., Palliative and hospice care in gynecologic cancer: a review. Gynecol Oncol 131:1 (Oct 2013), 215–221.
8. [8] Keating, N.L., Landrum, M.B., Rogers, S.O. Jr., et al. Physician factors associated with discussions about end-of-life care. Cancer 116:4 (Feb 15 2010), 998–1006.
9. [9] Huskamp, H.A., Keating, N.L., Malin, J.L., et al. Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med 169:10 (May 25 2009), 954–962.
10. [10] Keating, N.L., Herrinton, L.J., Zaslavsky, A.M., Liu, L., Ayanian, J.Z., Variations in hospice use among cancer patients. J Natl Cancer Inst 98:15 (Aug 2 2006), 1053–1059.
11. [11] Waldrop, D., Kirkendall, A.M., Rural–urban differences in end-of-life care: implications for practice. Soc Work Health Care 49:3 (2010), 263–289.
12. [12] Virnig, B.A., Moscovice, I.S., Durham, S.B., Casey, M.M., Do rural elders have limited access to Medicare hospice services?. J Am Geriatr Soc 52:5 (May 2004), 731–735.
13. [13] Casey, M.M., Moscovice, I.S., Virnig, B.A., Durham, S.B., Providing hospice care in rural areas: challenges and strategies. Am J Hosp Palliat Care 22:5 (Sep–Oct 2005), 363–368.
14. [14] Virnig, B.A., Kind, S., McBean, M., Fisher, E., Geographic variation in hospice use prior to death. J Am Geriatr Soc 48:9 (Sep 2000), 1117–1125.
15. [15] Cohen, L.L., Racial/ethnic disparities in hospice care: a systematic review. J Palliat Med 11:5 (Jun 2008), 763–768.
16. [16] Virnig, B.A., Morgan, R.O., Persily, N.A., DeVito, C.A., Racial and income differences in use of the hospice benefit between the Medicare managed care and Medicare fee-for-service. J Palliat Med 2:1 (Spring 1999), 23–31.
17. [17] Fairfield, K.M., Murray, K.M., Wierman, H.R., et al. Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol 125:1 (Apr 2012), 14–18.
18. [18] Sharma, R.K., Prigerson, H.G., Penedo, F.J., Maciejewski, P.K., Male–female patient differences in the association between end-of-life discussions and receipt of intensive care near death. Cancer 121:16 (Aug 15 2015), 2814–2820.
19. [19] Benton, K., Stephens, J., Vogel, R., et al. The influence of race on end-of-life choices following a counselor-based palliative consultation. Am J Hosp Palliat Care 32:1 (Feb 2015), 84–89.
20. [20] Cintron, A., Hamel, M.B., Davis, R.B., Burns, R.B., Phillips, R.S., McCarthy, E.P., Hospitalization of hospice patients with cancer. J Palliat Med 6:5 (Oct 2003), 757–768.
21. [21] Ramey, S.J., Chin, S.H., Disparity in hospice utilization by African American patients with cancer. Am J Hosp Palliat Care 29:5 (Aug 2012), 346–354.
22. [22] Drisdom, S., Barriers to using palliative care: insight into African American culture. Clin J Oncol Nurs 17:4 (Aug 1 2013), 376–380.
23. [23] Ngo-Metzger, Q., Phillips, R.S., McCarthy, E.P., Ethnic disparities in hospice use among Asian-American and Pacific Islander patients dying with cancer. J Am Geriatr Soc 56:1 (Jan 2008), 139–144.
24. [24] LoPresti, M.A., Dement, F., Gold, H.T., End-of-life care for people with cancer from ethnic minority groups: a systematic review. Am J Hosp Palliat Care 33:3 (2016 Apr), 291–305.
25. [25] Koroukian, S.M., Warner, D.F., Owusu, C., Given, C.W., Multimorbidity redefined: prospective health outcomes and the cumulative effect of co-occurring conditions. Prev Chronic Dis, 12, 2015, E55.
26. [26] Koroukian, S.M., Murray, P., Madigan, E., Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol 24:15 (May 20 2006), 2304–2310.
27. [27] de Decker, L., Annweiler, C., Launay, C., Fantino, B., Beauchet, O., Do not resuscitate orders and aging: impact of multimorbidity on the decision-making process. J Nutr Health Aging 18:3 (Mar 2014), 330–335.
28. [28] Inouye, S.K., Studenski, S., Tinetti, M.E., Kuchel, G.A., Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 55:5 (May 2007), 780–791.
29. [29] Cigolle, C.T., Ofstedal, M.B., Tian, Z., Blaum, C.S., Comparing models of frailty: the Health and Retirement Study. J Am Geriatr Soc 57:5 (May 2009), 830–839.
30. [30] Langa, K.M., Larson, E.B., Karlawish, J.H., et al. Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity?. Alzheimers Dement 4:2 (Mar 2008), 134–144.
31. [31] Andrews, J.S., Cenzer, I.S., Yelin, E., Covinsky, K.E., Pain as a risk factor for disability or death. J Am Geriatr Soc 61:4 (Apr 2013), 583–589.
32. [32] Karikari-Martin, P., McCann, J.J., Farran, C.J., Hebert, L.E., Haffer, S.C., Phillips, M., Race, any cancer, income, or cognitive function: what influences hospice or aggressive services use at the end of life among community-dwelling Medicare beneficiaries?. Am J Hosp Palliat Care 33:6 (2016 Jul), 537–545.
33. [33] Scibetta, C., Kerr, K., McGuire, J., Rabow, M.W., The costs of waiting: implications of the timing of palliative care consultation among a cohort of decedents at a comprehensive cancer center. J Palliat Med 19:1 (2016 Jan), 69–75.
34. [34] Butcher, L., New Medicare program set to expend access to hospice. Oncol Times, 37(12), 2015, 1.
35. [35] Koroukian, S.M., Schiltz, N., Warner, D.F., et al. Combinations of chronic conditions, functional limitations, and geriatric syndromes that predict health outcomes. J Gen Intern Med 31:6 (Jun 2016), 630–637.
36. [36] Earle, C.C., Ayanian, J.Z., Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol 24:6 (Feb 20 2006), 838–840.
37. [37] Ferraro, K.F., Farmer, M.M., Utility of health data from social surveys: is there a gold standard for measuring morbidity?. Am Sociol Rev 64:2 (Apr 1999), 303–315.
38. [38] Lloyd-Jones, D.M., Martin, D.O., Larson, M.G., Levy, D., Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 129:12 (Dec 15 1998), 1020–1026.
39. [39] Polednak, A.P., Using cancer registries to assess the accuracy of primary liver or intrahepatic bile duct cancer as the underlying cause of death, 1999–2010. J Registry Manag 40:4 (Winter 2013), 168–175.
40. [40] Polednak, A.P., US death rates from myeloproliferative neoplasms, and implications for cancer surveillance. J Registry Manag 38:2 (Summer 2011), 87–92.
41. [41] Polednak, A.P., Phillips, C., Cancers coded as tongue not otherwise specified: relevance to surveillance of human papillomavirus-related cancers. J Registry Manag 41:4 (Winter 2014), 190–195.
42. [42] Polednak, A.P., Inaccuracies in oral cavity-pharynx cancer coded as the underlying cause of death on U.S. death certificates, and trends in mortality rates (1999–2010). Oral Oncol 50:8 (Aug 2014), 732–739.
43. [43] Penson, D.F., Albertsen, P.C., Nelson, P.S., Barry, M., Stanford, J.L., Determining cause of death in prostate cancer: are death certificates valid?. J Natl Cancer Inst 93:23 (Dec 5 2001), 1822–1823.
44. [44] Albertsen, P.C., Walters, S., Hanley, J.A., A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol 163:2 (Feb 2000), 519–523.
45. [45] Polednak, A.P., Trend (1999–2009) in U.S. death rates from myelodysplastic syndromes: utility of multiple causes of death in surveillance. Cancer Epidemiol 37:5 (Oct 2013), 569–574.